Skip to Content

Moderna seeks full FDA approval for its vaccine

Y0h1I1Jb-coronavirus-moderna-vaccin.jpg

CAMBRIDGE, Mass. (AP) — American pharmaceutical company Moderna says it has begun the process to win full U.S. regulatory approval for the use of its COVID-19 vaccine in adults.

Moderna announced Tuesday it has begun a “rolling submission” to the Food and Drug Administration of data from its studies of the two-dose vaccine.

Moderna’s vaccine already has been cleared for emergency use by the FDA and regulators in numerous other countries. So far, more than 124 million doses have been administered in the United States.

Large-scale studies of the shots continued after Moderna’s emergency authorization. The FDA will scrutinize the information to see if the vaccine meets stringent criteria for full licensure.

Moderna is the second COVID-19 vaccine maker to seek full approval, following Pfizer and German partner BioNTech.

Last week, Moderna also announced that its vaccine appears safe and effective in kids as young as 12. The company plans to seek emergency authorization for teen use this month.

Coronavirus resources

  • Click here for the latest CDC novel coronavirus resources and links
  • Track the COVID-19 globally using this map tracker here
  • You can view the latest Indiana COVID-19 numbers here
  • Track Ohio's coronavirus numbers here
  • You can catch up on the latest Fort Wayne's NBC coronavirus coverage here
  • Sign up here for the latest local, state and national news regarding COVID-19
  • Click here to sign up for Fort Wayne's NBC News and Weather Alerts
Author Profile Photo

Associated Press

Skip to content